Omnicell (NASDAQ: OMCL) insider transactions
In the twelve months to 10 November 2026, executives and directors of Omnicell reported 11 open-market sales of 77,059 shares ($3.0m) and 0 open-market purchases, by 3 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 17 August 2026 | Njoku Nnamdi | President & COO | Open-market sale, 10b5-1 plan | −3,083 | $36.85 | 161,224 | Form 4 |
| 15 August 2026 | Lipps Randall A | Chairman, CEO | Shares withheld for tax | −12,350 | $37.30 | 511,096 | Form 4 |
| 15 August 2026 | Nutt Brian H. | VP, Chief Accounting Officer | Shares withheld for tax | −937 | $37.30 | 22,266 | Form 4 |
| 15 August 2026 | Manley Corey J | Evp&chief Legal/admin Officer | Shares withheld for tax | −4,025 | $37.30 | 108,985 | Form 4 |
| 15 August 2026 | Njoku Nnamdi | President & COO | Shares withheld for tax, 10b5-1 plan | −3,670 | $37.30 | 164,307 | Form 4 |
| 15 July 2026 | Lipps Randall A | Chairman, CEO | Open-market sale, 10b5-1 plan | −10,000 | $47.00 | 345,861 | Form 4 |
| 1 July 2026 | Njoku Nnamdi | President & COO | Grant or award | +12,309 | — | 167,094 | Form 4 |
| 1 June 2026 | Parrish Mark W | Director | Grant or award | +4,845 | — | 70,100 | Form 4 |
| 1 June 2026 | Seim Robin Gene | Director | Grant or award | +4,845 | — | 52,198 | Form 4 |
| 1 June 2026 | Bauer Joanne B | Director | Grant or award | +5,027 | — | 49,922 | Form 4 |
| 1 June 2026 | Bousa Edward Peter | Director | Grant or award | +4,603 | — | 22,589 | Form 4 |
| 1 June 2026 | Garrett Mary | Director | Grant or award | +5,027 | — | 22,202 | Form 4 |
| 1 June 2026 | Voynick Eileen J. | Director | Grant or award | +4,785 | — | 20,011 | Form 4 |
| 1 June 2026 | Scott Bruce E | Director | Grant or award | +4,627 | — | 27,600 | Form 4 |
| 1 June 2026 | Ghoshal Kaushik | Director | Grant or award | +4,603 | — | 19,123 | Form 4 |
| 18 May 2026 | Manley Corey J | Evp&chief Legal/admin Officer | Open-market sale, 10b5-1 plan | −5,025 | $43.22 | 112,783 | Form 4 |
| 18 May 2026 | Njoku Nnamdi | EVP, Chief Operating Officer | Open-market sale, 10b5-1 plan | −3,090 | $43.22 | 154,785 | Form 4 |
| 15 May 2026 | Lipps Randall A | Chairman, President undefined and CEO | Shares withheld for tax | −12,347 | $43.12 | 523,184 | Form 4 |
| 15 May 2026 | Nutt Brian H. | VP, Chief Accounting Officer | Shares withheld for tax | −226 | $43.12 | 22,860 | Form 4 |
| 15 May 2026 | Manley Corey J | Evp&chief Legal/admin Officer | Shares withheld for tax, 10b5-1 plan | −4,041 | $43.12 | 117,808 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Omnicell page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.